synageva
Alexion makes $8.4 billion Synageva purchase
May 7, 2015Research and Development, Sales and Marketing Alexion, Shire, nps, rare disease, synageva
Rare disease specialist firm Alexion is splashing out $8.4 billion to buy fellow US orphan drug developer Synageva biopharmaceuticals. The …
Senior J&J head appointed by Synageva
September 23, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing J&J, JJ, rob bazemore, synageva
US biopharma firm Synageva has appointed Robert Bazemore as its chief operating officer. Reporting directly to the president and chief …
Latest content
EnteroBiotix appoints former GSK Chief Medical Officer to board
November 3, 2026
AI: an early warning system for patient safety
November 3, 2026
